The rise of the AI analyst: How agentic AI will reshape life sciences consulting
Every time I walk into a room to meet a new client, I am asked: “So, what exactly are you bringing to this engagement that we can’t do ourselves?”
It’s a fair question. And the honest answer is never just about me. Yes, I have over twenty years of experience applying AI and data science to healthcare and pharma. Yes, I trained as a physician before moving into this space, and that clinical foundation shapes how I think about every problem. But that’s only part of the story.
What I actually bring is a team of specialists — regulatory experts, data scientists, competitive intelligence analysts — each contributing knowledge I don’t have on my own. We work with a proven methodology refined over years of client engagements. And I have access to decades of curated, continuously updated data covering regulatory decisions, clinical trials, patents, and competitive landscapes across every major therapeutic area and geography. Take away any one of those layers, and I’m just a smart person with opinions. Together, they make me genuinely useful.
I think about that question often now, because we are building something that works in exactly the same way — except the “consultant” walking into that room is an AI agent.
The anatomy of value
What makes a life sciences consultant valuable? When I break it down, there are three things.
Knowledge: years of accumulated understanding of regulatory frameworks, competitive landscapes, clinical development pathways, and market dynamics. When a regulatory consultant reads a new EMA guideline, they don’t read it in isolation. They read it against a decade of precedent, cross-referencing how agencies have historically interpreted similar provisions, combined with a deep understanding of the industry and, most importantly, the client’s operations, focus areas and challenges.
Access to tools and data: Consultants don’t work from memory alone. We rely on premium intelligence platforms — regulatory databases, clinical trial registries, patent analytics, competitive intelligence feeds, safety databases and scientific literature knowledge bases. A significant part of my team’s value lies in knowing which data to pull, from where, and how to interpret it.
Methodology: the structured, repeatable processes by which raw data becomes insight. Consultants, at least not all of them, don’t dump pipeline data into a spreadsheet and call it analysis. We apply frameworks for assessing impact levels and opportunities, weighting clinical probability of success, and mapping competitive positioning against unmet medical need.
Now here’s the question I keep coming back to: which of these qualities is inherently human?
Agents as composite analysts
An AI agent, properly constructed, can embody all three. I know this because I’ve been building them.
An agent can be equipped with deep domain knowledge encoded into structured instructions — often referred as skills — that describe not just what the agent should do, but how it should apply reason to a problem. A regulatory impact skill, for instance, encodes the analytical framework that a senior regulatory affairs professional would apply: how to identify affected product categories, how to assess the severity of a compliance gap, how to map downstream operational impact across quality, manufacturing, clinical, and commercial functions. I’ve spent months translating what I know — and what my colleagues know — into these structured skill definitions, and the difference between an agent with a well-crafted skill and one without is the difference between a junior analyst and a seasoned expert.
The agent can be connected to high-quality, curated data sources on demand. Rather than relying on stale training data, it can query regulatory intelligence platforms, clinical trial databases, patent registries, and market analytics in real time — the same premium data sources that I rely on daily. The difference is that the agent can do this at scale, across multiple queries, in seconds rather than days.
And the agent can apply methodology consistently. Unlike me on a Friday afternoon after three back-to-back client calls, an agent applies its analytical framework with the same rigour on its thousandth assessment as on its first.
The CV problem
But here’s where the analogy gets personal. When I sit in this client meeting room, my credibility rests on my track record. My CV. The engagements I have delivered, the problems I have solved, the clients who trusted me enough to come back. Nobody hired me because I claimed to be an expert; they hired me because I could demonstrate it.
Agents will face the same proving ground. An agent that claims to perform regulatory impact assessments is only as credible as the assessments it has actually delivered. Over time, the most valuable agents will be those that can point to a measurable track record: hundreds of assessments completed, validated against expert review, with quantifiable accuracy rates and documented edge cases where they correctly identified risks that others missed. The agent’s “CV” will be a performance dashboard — a living record of precision, consistency, and client outcomes.
This is already happening. I’m part of a team building agent systems that perform regulatory intelligence workflows, competitive landscape analyses, and clinical trial data extraction at production scale. Human experts review every output and feed corrections back into the system. Each review cycle sharpens the agent’s capabilities, just as each project in my career has sharpened mine.
The irreplaceable human
None of this makes human experts obsolete — it makes them more important than ever. The most critical insight in this entire shift is that agents don’t build themselves.
Behind every effective AI analyst is a human expert who has done the painstaking work of encoding their knowledge into skills, selecting and validating the data sources the agent will use, defining the analytical frameworks it will follow, and establishing the quality standards against which its outputs will be measured. This is a new form of expertise: the ability to translate decades of professional knowledge into structured instructions that an AI system can execute reliably. It requires not just domain mastery, but a kind of meta-cognition — the ability to articulate what you know, why you know it, and how you apply it, with enough precision for a machine to follow.
And the work doesn’t end at creation. Agents operating in regulated industries require ongoing monitoring, calibration, and governance. Regulatory landscapes shift. New agency guidance changes the interpretation of existing rules. Novel therapeutic modalities create categories that didn’t exist when the agent’s skills were written. Human experts must continuously update, validate, and refine their agents — just as a consulting firm invests in the professional development of its people.
The future is hybrid
The life sciences industry won’t replace its consultants with agents overnight. But it is creating a new operating model where human expertise is amplified by agent capabilities. The regulatory expert who once spent three days manually reviewing a guidance document and cross-referencing it against a client’s portfolio can now direct an agent to perform that analysis in minutes, review the output with expert eyes, and spend their time on the higher-order strategic questions that no agent can yet answer.
If someone asked me today what I bring to an engagement, my answer would be different. I’d say: I bring everything I brought before — the experience, the methodology, the data. But now I also bring agents that I’ve trained, equipped, and validated to work alongside me. They extend my reach. They never get tired. And their track record is something you can measure.
The age of the AI analyst isn’t the end of human expertise in life sciences. It’s the beginning of its most powerful expression yet.
Learn more about how Clarivate technology consulting helps customers optimize their technology capabilities here: Healthcare Technology Consulting Services | Clarivate
